Sunday May 22, 2022
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International US West
    • |BioProcess International Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Manufacturing

Partnering with Your CMO for a Successful Preapproval Inspection

by BPI Contributor
Add Comment
December 1, 2004

Compliance Issues for Innovator and Generic Biopharmaceuticals

by BPI Contributor
Add Comment
December 1, 2004

Enhancing Therapeutic Antibodies and Titer Yields of Mammalian Cell Lines

by BPI Contributor
Add Comment
November 1, 2004

Compliance Issues for Innovator and Generic Biopharmaceuticals

by BPI Contributor
Add Comment
November 1, 2004

Disposable Assemblies in Biopharmaceutical Production

by BPI Contributor
Add Comment
October 1, 2004

Considerations for Use of Disposable Technology in Contract Manufacturing

by BPI Contributor
Add Comment
October 1, 2004

Biomanufacturing for the 21st Century

by BPI Contributor
Add Comment
October 1, 2004

Would Your Company Survive Disaster?

by BPI Contributor
Add Comment
September 1, 2004

Navigating FDA Regulations for Human Cells and Tissues

by BPI Contributor
Add Comment
September 1, 2004

European Comparability Guidances Acknowledge Follow-On Manufacturers

by BPI Contributor
Add Comment
September 1, 2004
  • <
  • 1
  • ...
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • ...
  • 100
  • >

Editor’s Choice

  • BioProcess Insider

    Cell and gene therapy processing: Iteration or innovation?

  • BioProcess Insider

    CAR-T approvals marred by autologous manufacturing limitations, says Allogene

  • Sponsored Content

    Ending CO2 Transmission Problems Using Purillex® Containers

  • BioProcess Insider

    Robo-bloc: Multiply labs welcomes Thermo Fisher and Charles River

  • BioProcess Insider

    Regenxbio: ‘CDMO issue validates inhouse gene therapy investment’

  • Sponsored Content

    Regulatory Testing for Cell and Gene Therapies: Meeting the Challenges

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: Two co-founders of Taiwanese firm JHL Biotech were sentenced last month for plotting to steal trade secrets from Ge… https://t.co/0iclK4yS7h 1 month ago
  • Tweet Avatar RT @frankvinluan: Shutdown comes 8 months after FDA sent a warning letter about a #microbiome metabolic therapy the #biotech was test… https://t.co/FgtTS54Yj0 1 month ago
  • Tweet Avatar RT @Dan5tanton: A win for CDMO Catalent as it further strengthens its global network, but potentially a loss to the UK taxpayer, wh… https://t.co/Ex9CNdbcf0 1 month ago
  • Tweet Avatar RT @Dan5tanton: The US Department of Health and Human Services #HHS has terminated a long-term #CDMO partnership with Emergent BioS… https://t.co/bAbKWb3uqQ 6 months ago
Follow @bioproinsider

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2022 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International US West
    • BioProcess International Europe
  • BioProcess International Academy
  • Events